We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.88T
1-Year Est. Return 44.46%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
-14.64%
1 Year Est. Return
+44.46%
3 Year Est. Return
+136.69%
5 Year Est. Return
+180.19%
10 Year Est. Return
+697.06%
AUM
$683B
AUM Growth
-$118B
Cap. Flow
+$16.8B
Cap. Flow %
2.46%
Top 10 Hldgs %
22.55%
Holding
5,106
New
131
Increased
2,878
Reduced
1,465
Closed
89

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$956M
2
AAPL icon
Apple
AAPL
+$935M
3
WBD icon
Warner Bros
WBD
+$783M
4
HD icon
Home Depot
HD
+$626M
5
AMZN icon
Amazon
AMZN
+$476M

Sector Composition

Rank Sector Weight
1 Technology 23.95%
2 Healthcare 14.76%
3 Financials 13.17%
4 Consumer Discretionary 10.3%
5 Industrials 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APVO icon
4301
Aptevo Therapeutics
APVO
$5.31M
0
ARBG
4302
DELISTED
Aequi Acquisition Corp
ARBG
$189K ﹤0.01%
19,142
NTRB icon
4303
Nutriband
NTRB
$37.4M
$188K ﹤0.01%
53,446
+1,684
+3% +$6.13K
ABEO icon
4304
Abeona Therapeutics
ABEO
$425M
$187K ﹤0.01%
35,939
+2,970
+9% +$15K
EXK
4305
Endeavour Silver
EXK
$3.14B
$187K ﹤0.01%
59,891
+14,228
+31% +$56.1K
MIRO
4306
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
$187K ﹤0.01%
47,089
+25,419
+117% +$97.4K
TBCP
4307
DELISTED
Thunder Bridge Capital Partners III Inc. Class A Common Stock
TBCP
$187K ﹤0.01%
19,136
BCYC
4308
Bicycle Therapeutics
BCYC
$283M
$186K ﹤0.01%
11,133
IGIC icon
4309
International General Insurance
IGIC
$1.13B
$186K ﹤0.01%
24,436
KSCP icon
4310
Knightscope
KSCP
$29.4M
$186K ﹤0.01%
+1,240
New +$238K
PED icon
4311
PEDEVCO
PED
$151M
$186K ﹤0.01%
8,114
+590
+8% +$15.1K
MDWT
4312
DELISTED
Midwest Holding Inc. Common Stock
MDWT
$186K ﹤0.01%
15,515
+601
+4% +$7.23K
ISO
4313
DELISTED
IsoPlexis Corporation Common Stock
ISO
$186K ﹤0.01%
86,248
-69,103
-44% -$161K
FTPA
4314
DELISTED
FTAC Parnassus Acquisition Corp. Class A Common Stock
FTPA
$186K ﹤0.01%
+18,931
New +$186K
ISLE
4315
DELISTED
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
$186K ﹤0.01%
18,688
NRXP icon
4316
NRX Pharmaceuticals
NRXP
$143M
$185K ﹤0.01%
30,843
+1,456
+5% +$19.1K
WHLR
4317
Wheeler Real Estate Investment Trust
WHLR
$398K
0
XPL icon
4318
Solitario Resources
XPL
$73.6M
$185K ﹤0.01%
326,055
+14,073
+5% +$9.69K
ARGU
4319
DELISTED
Argus Capital Corp. Class A Common Stock
ARGU
$185K ﹤0.01%
+18,585
New +$186K
FABC
4320
Fabric.AI Inc
FABC
$18M
$183K ﹤0.01%
1,708
+108
+7% +$14K
DSS icon
4321
DSS Inc
DSS
$5.15M
$183K ﹤0.01%
28,163
+1,456
+5% +$11.6K
DMRA
4322
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.92B
$183K ﹤0.01%
4,245
+358
+9% +$16.4K
ADIL
4323
Adial Pharmaceuticals
ADIL
$9.43M
$182K ﹤0.01%
217
+1
+0.5% +$906
DRTS icon
4324
Alpha Tau Medical
DRTS
$1.25B
$182K ﹤0.01%
+20,242
New +$181K
PCSA icon
4325
Processa Pharmaceuticals
PCSA
$8.58M
$182K ﹤0.01%
130

Similar funds

Geode Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Geode Capital Management held 5,106 positions worth $683B, down 15% from $801B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 4.3%. Geode Capital Management opened 131 new positions and exited 89, leaving the 5,106-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q2 2022 buy was Aspen Technology Inc: 402,046 shares worth $74M.
  • Geode Capital Management added most to Microsoft in Q2 2022, an estimated $956M increase.
  • Geode Capital Management's biggest Q2 2022 reduction was AT&T, cutting an estimated $734M.
  • Geode Capital Management fully exited Cerner Corp in Q2 2022, selling an estimated $600M.
  • Geode Capital Management's ten largest holdings make up 23% of its $683B portfolio in Q2 2022.
  • Geode Capital Management opened 131 new positions and closed 89 in Q2 2022.
  • Geode Capital Management's portfolio value fell 15% quarter-over-quarter to $683B.

Based on Geode Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.